image dons

I make a donation

ACCOST-HH

Adrecizumab - Adrenomedullin - Cardiogenic shock

Publication presented by Anthony KECHICHIAN

On January 25, 2022

Title: Adrecizumab Versus Placebo in Acute Cardiogenic Shock: A Randomised Multicentre Control Trial

Reference: The Lancet, December 2021

Autres actualités

+

18/02/2025


The VANISH2 Trial

ICD - Ventricular tachycardia - Antiarrhythmic drugs
+

11/02/2025


The MANIFEST-REDO Study

AF - Electroporation - PVI
+

28/01/2025


The TAVR UNLOAD Trial

AVR - Aortic Stenosis - HF